Pinnacle Financial Partners (Georgia)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Buy
298,653
+2,424
+0.8% +$139K 0.12% 143
2026
Q1
$18M Buy
296,229
+4,931
+2% +$287K 0.14% 130
2025
Q4
$15.7M Buy
+291,298
New +$14M 0.12% 138

Other funds holding BMY

Pinnacle Financial Partners (Georgia)'s BMY Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its Bristol-Myers Squibb (BMY) stake by 0.82% in Q2 2026, buying an estimated $139K and bringing the position to 298,653 shares worth $17.2M. The position accounts for 0.12% of the portfolio, ranked #143.

Pinnacle Financial Partners (Georgia) first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $18M in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 298,653 shares of Bristol-Myers Squibb worth $17.2M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 2,424 Bristol-Myers Squibb shares in Q2 2026, an estimated $139K.
  • Bristol-Myers Squibb made up 0.12% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #143 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Financial Partners (Georgia)'s Bristol-Myers Squibb position peaked at $18M in Q1 2026.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.